Rocket Pharmaceuticals (RCKT) PT Raised to $24 at Raymond James
Tweet
Share
E-mailGet Alerts RCKT Hot Sheet
Price: $3.79 -1.81%
Rating Summary:
15 Buy, 7 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 28
Rating Summary:
15 Buy, 7 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 28
Join SI Premium – FREE
Raymond James analyst Timur Ivannikov raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $24.00 (from $22.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy
- CLSA Downgrades Heineken Malaysia Bhd (HEIM:MK) to Hold (3)
- CIENA (CIEN) PT Raised to $600 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
